These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vascular protectants for the treatment of atherosclerosis. Tardif JC; Grégoire J; Lavoie MA; L'Allier PL Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):385-92. PubMed ID: 15030266 [TBL] [Abstract][Full Text] [Related]
6. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC; Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365 [TBL] [Abstract][Full Text] [Related]
7. Antioxidants: the good, the bad and the ugly. Tardif JC Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):61B-65B. PubMed ID: 16498514 [TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth. Doggrell SA Expert Opin Investig Drugs; 2003 Nov; 12(11):1855-9. PubMed ID: 14585060 [TBL] [Abstract][Full Text] [Related]
9. AGI-1067: a novel vascular protectant for prevention of restenosis. Franks AM; Gardner SF Ann Pharmacother; 2006 Jan; 40(1):66-73. PubMed ID: 16303986 [TBL] [Abstract][Full Text] [Related]
10. AGI-1067, a novel vascular protectant, anti-inflammatory drug and mild antiplatelet agent for treatment of atherosclerosis. Serebruany VL; Malinin A; Eisert C; Ong S Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):635-41. PubMed ID: 17605642 [TBL] [Abstract][Full Text] [Related]
11. Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease. Wasserman MA; Sundell CL; Kunsch C; Edwards D; Meng CQ; Medford RM Am J Cardiol; 2003 Feb; 91(3A):34A-40A. PubMed ID: 12645642 [TBL] [Abstract][Full Text] [Related]
12. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent. Sundell CL; Somers PK; Meng CQ; Hoong LK; Suen KL; Hill RR; Landers LK; Chapman A; Butteiger D; Jones M; Edwards D; Daugherty A; Wasserman MA; Alexander RW; Medford RM; Saxena U J Pharmacol Exp Ther; 2003 Jun; 305(3):1116-23. PubMed ID: 12626663 [TBL] [Abstract][Full Text] [Related]
13. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125 [TBL] [Abstract][Full Text] [Related]
14. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. Kunsch C; Luchoomun J; Grey JY; Olliff LK; Saint LB; Arrendale RF; Wasserman MA; Saxena U; Medford RM J Pharmacol Exp Ther; 2004 Mar; 308(3):820-9. PubMed ID: 14617690 [TBL] [Abstract][Full Text] [Related]
17. Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Anderson TJ; Reeves F; Title LM; Schampaert E; LeMay M; Lespérance J; Scott R; Guertin MC; Brennan ML; Hazen SL; Bertrand OF; Atherosclerosis; 2008 Mar; 197(1):480-6. PubMed ID: 17214993 [TBL] [Abstract][Full Text] [Related]
18. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Schneider JE; Berk BC; Gravanis MB; Santoian EC; Cipolla GD; Tarazona N; Lassegue B; King SB Circulation; 1993 Aug; 88(2):628-37. PubMed ID: 8339427 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of anti-atherogenic action of probucol]. Ohya T; Egusa G Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221 [TBL] [Abstract][Full Text] [Related]
20. Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. Kim W; Jeong MH; Cha KS; Hyun DW; Hur SH; Kim KB; Hong YJ; Park HW; Kim JH; Ahn YK; Kim MH; Cho JG; Park JT; Park JC; Kang JC Circ J; 2005 Jan; 69(1):101-6. PubMed ID: 15635212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]